Laboratorios Farmaceuticos Rovi, S.A. will propose to the General Shareholders' Meeting a dividend of EUR 1.2938 per share charged to the 2022 profit and retained earnings. This proposed dividend would mean an increase of 35% on the dividend charge to the 2021 profit and represents the same 35% of the net profit for 2022 attributed to the parent company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.75 EUR | +0.41% | +4.12% | +40.78% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+40.78% | 4.73B | |
+30.54% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+14.77% | 239B | |
+9.84% | 210B | |
-7.48% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.
- Laboratorios Farmaceuticos Rovi, S.A. Proposes Dividend for the Year 2022